Haoxi Health Technology Limited HAO

2.90 (0.07) (2.36%) as of 25 Sep
Market cap
$1.8M
P/E
—
Insider Buys alert about insiders buying in the last 12 month
Jun '25 Jun '24 Jun '23 Dec '22 Jun '22 Dec '21 Jun '21
P/FCF ratio
0.00 0.00 0.00 — 0.00 0.00 0.00
P/Operating CF
0.00 0.00 0.00 — 0.00 0.00 0.00
P/B ratio
0.00 0.00 0.00 — 0.00 0.00 0.00
EV/Sales
0.00 0.00 0.00 — 0.00 0.00 0.00
EV/EBITDA
0.00 0.00 0.00 — 0.00 0.00 0.00
EV/FCF
1.09 2.60 0.00 — 0.00 0.00 0.00
Current Ratio
5.05 3.98 1.43 0.00 0.22 0.22 0.22
Net Debt/EBITDA
4.12 (3.20) (0.37) (0.31) 0.54 (1.09) (1.09)
Debt/Equity
0.11 0.10 0.49 0.00 (0.30) 0.00 0.00
ROE
27.06% 20.12% 1,924.21% 0.00% (16.29%) (15.90%) 0.00%
ROA
20.90% 12.94% 43.37% 352.21% 45.05% 45.05% 0.00%
ROIC
(11.71%) 18.66% 66.50% (202.75%) 0.00% 0.00% 0.00%
Return on Tangible Assets
24.49% 11.10% 78.12% 12,594.81% (15.74%) (15.74%) (15.74%)
Average Days of Receivables
5.12 1.71 0.10 0.00 0.09 0.09 0.09
Free Cash Flow Yield
0.00% 0.00% 0.00% — 0.00% 0.00% 0.00%
Free Cash Flow per Share
(6,042.33) (1,606.00) (2,294.00) — (1,710.25) — —
Book value per Share
19,307.11 22,544.00 3,916.25 — (3,664.25) 0.00 0.00
Free Cash Flow
(5.44) (0.80) (0.92) — (0.68) — —
EV/EBIT
0.00 0.00 0.00 — 0.00 0.00 0.00
Other line items

Show all line items

Columns are period end dates